Motilal Oswal: Dr. Reddy’s New Drug Application Xeglyze Approval To Improve Out-Licensing Prospects 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.